A Phase 2b Study of Pirepemat in Parkinson's Disease Patients

Completed Phase 2 NCT05258071

Study Description

A Clinical Study Evaluating the Effectiveness of Pirepemat in Reducing Falls in Parkinson's Disease Patients

Study Details

Registry ID:
NCT05258071
Conditions:
Parkinson Disease
Phase:
Phase 2
Target Enrollment:
104 participants
Start Date:
Age Range:
55–85 years
Healthy Volunteers:
No

Study Locations (59 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →